Mark S. Levine has sold stock and made no open-market buys since Jan 2017

General Counsel at Immunovant, Inc., and 2 other companies

SEC CIK 0001617236 · Filings on SEC.gov ↗

$0Bought

$2.6MSold

NoneLast buy

Companies

Every filing

21 filings since Jan 2017, newest first

IMVTSell

Immunovant, Inc.

General Counsel

$93K−1.0%Nov 22

IMVTSell

Immunovant, Inc.

General Counsel

$129K−1.0%Oct 25

IMVTSell

Immunovant, Inc.

General Counsel

$82K−1.0%Oct 18

IMVTSell

Immunovant, Inc.

General Counsel

$105K−1.0%Aug 23

IMVTSell

Immunovant, Inc.

General Counsel

$111K−1.0%Jul 26

IMVTSell

Immunovant, Inc.

General Counsel

$74K−1.0%Jul 19

IMVTSell

Immunovant, Inc.

General Counsel

$96K−1.0%May 24

IMVTSell

Immunovant, Inc.

General Counsel

$115K−1.0%Apr 26

IMVTSell

Immunovant, Inc.

General Counsel

$286K−3.0%Apr 19

IMVTSell

Immunovant, Inc.

General Counsel

$77K−1.0%Feb 23

IMVTSell

Immunovant, Inc.

General Counsel

$115K−1.0%Jan 29

IMVTSell

Immunovant, Inc.

General Counsel

$107K−1.0%Nov 24

IMVTSell

Immunovant, Inc.

General Counsel

$142K−1.0%Oct 27

IMVTSell

Immunovant, Inc.

General Counsel

$249K−4.0%Aug 25

IMVTSell

Immunovant, Inc.

General Counsel

$85K−1.0%Jul 27

IMVTSell

Immunovant, Inc.

General Counsel

$43K−1.0%Apr 26

IMVTSell

Immunovant, Inc.

General Counsel

$188K−4.0%Jan 27

FLXNSell

Flexion Therapeutics Inc

General Counsel

$25K−3.0%Jul 20

FLXNSell

Flexion Therapeutics Inc

General Counsel

$76K−6.0%Jan 7

NERVSell

Minerva Neurosciences, Inc.

SVP,GC, Sec.

$193K−100.0%Jun 5

NERVSell

Minerva Neurosciences, Inc.

SVP,GC, Sec.

$210K−100.0%Jan 6

Filings come from SEC EDGAR. Not investment advice.